[{"Assets_0_Q2_USD":4441600000.0,"CIK":"1596783","CommonStockSharesConverted_0_Q2_shares":145221009.0,"CommonStockSharesOutstanding_0_Q2_shares":145221009.0,"Country":"United States","EarningsPerShareBasic_1_Q2_USD":0.34,"EarningsPerShareBasic_2_Q2_USD":0.24,"EarningsPerShareDiluted_1_Q2_USD":0.33,"EarningsPerShareDiluted_2_Q2_USD":0.24,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"17076283108.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":84500000.0,"NetIncomeLossConverted_1_Q2_USD":49000000.0,"NetIncomeLossConverted_2_Q2_USD":34600000.0,"OfficialName":"Catalent Inc. Common Stock","RevenuesConverted_1_Q2_USD":623000000.0,"RevenuesConverted_2_Q2_USD":1174800000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":1563000000.0,"StockholdersEquity_0_Q2_USD":1563000000.0,"Ticker":"CTLT","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":146660339.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":145061609.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":145058230.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":143285870.0,"filed":"20190205","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2019.0","name":"CATALENT, INC.","period":"20181231","qtrs":"0","uom":"USD"}]